FDA Drug recall D-0773-2016
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
- FDA Drug
- Class III
- terminated
- Published 2016-03-23
On 2016-03-23 the FDA classified a Class III recall of NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL by Teva Pharmaceuticals Usa, citing labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0773-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-11-19 |
| Published | 2016-03-23 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
Reason
Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.
Identifiers
| code_info | Lot #: 05N533, Exp 11/16 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0773-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.